Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H, Grunert S (2002) Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156:299–313
Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572
Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458
Tlsty TD, Hein PW (2001) Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11:54–59
de Visser K, Korets L, Coussens L (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Res 7:411–423
Kim K, Li B, Winer J, Armanini M, Gillett N, Phillips H, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841–844
Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124:263–266
Noel A, Foidart J-M (1998) The role of stroma in breast carcinoma growth in vivo. J Mammary Gland Biol Neoplasia V3:215–225
Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR (2002) Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 62:3298–3307
Mueller MM, Fusenig NE (2004) friends or foes- bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839–849
Roepman P, de Koning E, van Leenen D, de Weger R, Kummer JA, Slootweg P, Holstege F (2006) Dissection of a metastatic gene expression signature into distinct components. Genome Biol 7:R117
Yamabuki T, Daigo Y, Kato T, Hayama S, Tsunoda T, Miyamoto M, Ito T, Fujita M, Hosokawa M, Kondo S, Nakamura Y (2006) Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas. Int J Oncol 28(6):1375–1384
Nakamura N, Iijima T, Mase K, Furuya S, Kano J, Morishita Y, Noguchi M (2004) Phenotypic differences of proliferating fibroblasts in the stroma of lung adenocarcinoma and normal bronchus tissue. Cancer Sci 95:226–232
Finak G, Sadekova S, Pepin F, Hallett M, Meterissian S, Halwani F, Khetani K, Souleimanova M, Zabolotny B, Omeroglu A, Park M (2006) Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res 8:R58
Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410
R Development Core Team (2006) R: a language and environment for statistical computing. http://www.R-project.org
Gentleman R, Carey V, Bates D, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini A, Sawitzki G, Smith C, Smyth G, Tierney L, Yang J, Zhang J (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15
Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185–193
Falcon S, Gentleman R (2007) Using GOstats to test gene lists for GO term association. Bioinformatics 23:257–258
Marisa MF, Jérôme T, Marie-Ange D, Ilaria Taddei-De La H, Jean Paul T, Marina AG (2005) Myoepithelial cells in the control of mammary development and tumorigenesis: data from genetically modified mice. J Mammary Gland Biol Neoplasia 10:211–219
Woodward TL, Mienaltowski AS, Modi RR, Bennett JM, Haslam SZ (2001) Fibronectin and the {{alpha}}5{beta}1 integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology 142:3214–3222
Pujuguet P, Simian M, Liaw J, Timpl R, Werb Z, Bissell MJ (2000) Nidogen-1 regulates laminin-1-dependent mammary-specific gene expression. J Cell Sci 113:849–858
Nakano S, Iyama K, Ogawa M, Yoshioka H, Sado Y, Oohashi T, Ninomiya Y, (1999) Differential tissular expression and localization of type IV collagen alpha1(IV), alpha2(IV), alpha5(IV), and alpha6(IV) chains and their mRNA in normal breast and in benign and malignant breast tumors. Lab Invest 79:281–292
Silberstein GB, Daniel CW (1987) Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science 237:291–293
Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96
de Jong JS, van Diest PJ, Baak JP (2000) Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 36:306–312
de Jong JS, van Diest PJ, Baak JP (2000) Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br J Cancer 82:368–373
Liu S, Edgerton SM, Moore DH 2nd, Thor AD (2001) Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. Clin Cancer Res 7:1716–1723
Mori I, Yang Q, Kakudo K (2002) Predictive and prognostic markers for invasive breast cancer. Pathol Int 52:186–194
Srinivas P, Abraham E, Ahamed I, Madhavan M, Vijayalakshmi NR, Nair MK, Balaram P (2002) Apoptotic index: use in predicting recurrence in breast cancer patients. J Exp Clin Cancer Res 21:233–238
Vakkala M, Lahteenmaki K, Raunio H, Paakko P, Soini Y (1999) Apoptosis during breast carcinoma progression. Clin Cancer Res 5:319–324
Abba M, Drake J, Hawkins K, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K, Aldaz C (2004) Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Res 6:R499–R519
Grigoriadis A, Mackay A, Reis-Filho J, Steele D, Iseli C, Stevenson B, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson A, Strausberg R, Jat P, Ashworth A, Neville AM, O’Hare M (2006) Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res 8:R56
Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, Hajduch M, Murray P, Kolar Z (2007) Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 7:55
Folgueira M, Brentani H, Katayama M, Patrão D, Carraro D, Mourão Netto M, Barbosa E, Caldeira J, Abreu A, Lyra E, Kaiano J, Mota L, Campos A, Maciel M, Dellamano M, Caballero O, Brentani M (2006) Gene expression profiling of clinical stages II and III breast cancer. Braz J Med Biol Res 39:1101–1113
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale A-L, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747–752
Mesnil M, Crespin S, Avanzo J-L, Zaidan-Dagli M-L (2005) Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 1719:125–145
Stadler CR, Knyazev P, Bange J, Ullrich A (2006) FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression. Cell Signal 18:783–794
Friedl P, Wolf K (2003) Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem Soc Symp 70:277–285
Clark EA, Goiub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532–535
Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537–549
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518–524
Bradshaw A, Sage E (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049–1054
Barth PJ, Moll R, Ramaswamy A (2005) Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast. Virchows Arch 446:532–536
Robinson S, Silberstein G, Daniel CW (1992) Evidence supporting a role for TGF-beta isoforms in growth regulation and functional differentiation of the mouse mammary gland. In: Mechanisms regulating lactation and infant nutrient utilization. Wiley-Liss, Inc, New York, pp 43–52
Faler B, Macsata R, Plummer D, Mishra L, Sidawy A (2006) Transforming growth factor-beta and wound healing. Perspect Vasc Surg Endovasc Ther 18:55–62
O’Kane S, Ferguson MWJ (1997) Transforming growth factor [beta]s and wound healing. Int J Biochem Cell Biol 29:63–78
Fleisch MC, Maxwell CA, Barcellos-Hoff M-H (2006) The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs. Endocrinology 13:379–400
Muraoka-Cook RS, Dumont N, Arteaga CL (2005) Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression. Clin Cancer Res 11:937s–943s
Roberts A, Wakefield L (2003) The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA 100:8621–8623
Minond D, Lauer-Fields JL, Cudic M, Overall CM, Pei D, Brew K, Moss ML, Fields GB (2007) Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences. Biochemistry 46(12):3724–3733
Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS (2006) Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 4:437–447
Leivonen SK, Ala-aho R, Koli K, Grenman R, Peltonen J, Kahari VM (2006) Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 25:2588–2600
Lafleur M, Drew A, de Sousa E, Blick T, Bills M, Walker E, Williams E, Waltham M, Thompson E (2005) Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13. Int J Cancer 114:544–554
Andreas MS, Bartosz A, Rolf M, Toshiyuki Y, Mehdorn HM, Janka H-F (2007) Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells. J Neurooncol 81:39–48
Luukkaa M, Vihinen P, Kronqvist P, Vahlberg T, Pyrhönen S, Kähäri V, Grénman R (2006) Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck 28:225–234
Garin-Chesa P, Old LJ, Rettig WJ (1990) Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. PNAS 87:7235–7239
Niedermeyer J, Enenkel B, Park JE, Lenter M, Rettig WJ, Damm K, Schnapp A (1998) Mouse fibroblast-activation protein – conserved Fap gene organization and biochemical function as a serine protease. Eur J Biochem 254:650–654
Scanlan MJ, Raj BKM, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old LJ, Rettig WJ (1994) Molecular cloning of fibroblast activation protein {alpha}, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA 91:5657–5661
Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ (1999) Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 274:36505–36512
Rettig WJ, Garin-Chesa P, Beresford HR, Oettgen HF, Melamed MR, Old LJ (1988) Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci USA 85:3110–3114
Tahtis K, Lee F-T, Wheatley JM, Garin-Chesa P, Park JE, Smyth FE, Obata Y, Stockert E, Hall CM, Old LJ, Rettig WJ, Scott AM (2003) Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model. Mol Cancer Res 2:729–737
Scott IC, Blitz IL, Pappano WN, Imamura Y, Clark TG, Steiglitz BM, Thomas CL, Maas SA, Takahara K, Cho KWY, Greenspan DS (1999) Mammalian BMP-1/tolloid-related metalloproteinases, including novel family member mammalian tolloid-like 2, have differential enzymatic activities and distributions of expression relevant to patterning and skeletogenesis. Dev Biol 213:283–300
Veitch DP, Nokelainen P, McGowan KA, Nguyen T-T, Nguyen NE, Stephenson R, Pappano WN, Keene DR, Spong SM, Greenspan DS, Findell PR, Marinkovich MP (2003) Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J Biol Chem 278:15661–15668
Ishikawa T, Kamiyama M, Tani-Ishii N, Suzuki H, Ichikawa Y, Hamaguchi Y, Momiyama N, Shimada H (2001) Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides. Mol Carcinog 32:84–91
Lipton A (2005) New therapeutic agents for the treatment of bone diseases. Expert Opin Biol Ther 5:817–832
Turk V, Turk B, Guncar G, Turk D, Kos J (2002) Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv Enzyme Regul 42:285–303
Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA (2006) Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 20:543–556
Micke P, Kappert K, Ohshima M, Sundquist C, Scheidl S, Lindahl P, Heldin C-H, Botling J, Ponten F, Ostman A (2007) In situ identification of genes regulated specifically in fibroblasts of human basal cell carcinoma. J Invest Dermatol 127(6):1516–1523
Cockett M, Murphy G, Birch M, O’Connell J, Crabbe T, Millican A, Hart I, Docherty A (1998) Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp 63:295–313
Twal WO, Czirok A, Hegedus B, Knaak C, Chintalapudi MR, Okagawa H, Sugi Y, Argraves WS (2001) Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci 114:4587–4598
Hayashido Y, Lucas A et al (1998) Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer 75:654–658
Hubmacher D, Tiedemann K, Reinhardt DP, Gerald PS (2006) Fibrillins: from biogenesis of microfibrils to signaling functions. In: Current topics in developmental biology. Academic Press, pp 93–123
Weir M, Oppizzi M, Henry M, Onishi A, Campbell K, Bissell M, Muschler J (2006) Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring. J Cell Sci 119:4047–4058
Barresi R, Campbell K (2006) Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119:199–207
Young KG, Pinheiro B, Kothary R (2006) A Bpag1 isoform involved in cytoskeletal organization surrounding the nucleus. Exp Cell Res 312:121–134
Roper K, Gregory SL, Brown NH (2002) The ‘Spectraplakins’: cytoskeletal giants with characteristics of both spectrin and plakin families. J Cell Sci 115:4215–4225
Carraway KL, Sweeney C (2006) Co-opted integrin signaling in ErbB2-induced mammary tumor progression. Cancer Cell 10:93–95
Singer C, Kronsteiner N, Marton E, Kubista M, Cullen K, Hirtenlehner K, Seifert M, Kubista E (2002) MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Br Cancer Res Treat 72:69–77
Basset P, Wolf C, Chambon P (1993) Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Br Cancer Res Treat 24:185–193
Okada A, Bellocq J, Rouyer N, Chenard M, Rio M, Chambon P, Basset P (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92:2730–2734
Polette M, Gilles C, Marchand V, Lorenzato M, Toole B, Tournier J-M, Zucker S, Birembaut P (1997) Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem 45:703–710
Tang Y, Kesavan P, Nakada MT, Yan L (2004) Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2:73–80
Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL (2004) TGF-{beta} signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848–851
Joesting MS, Perrin S, Elenbaas B, Fawell SE, Rubin JS, Franco OE, Hayward SW, Cunha GR, Marker PC (2005) Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res 65:10423–10430
Ronnov-Jessen L, Petersen OW, Bissell MJ (1996) Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76:69–125
Barcellos-Hoff MH, Ravani SA (2000) Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 60:1254–1260
Barcellos-Hoff MH (1993) Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res 53:3880–3886
Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, Arteaga CL, Neilson EG, Hayward SW, Moses HL (2005) Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 24:5053–5068
Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA (2000) Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 60:2562–2566
Parrott JA, Nilsson E, Mosher R, Magrane G, Albertson D, Pinkel D, Gray JW, Skinner MK (2001) Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells. Mol Cell Endocrinol 175:29–39
Fukumura D, Xavier R, Sugiura T, Chen Y, Park E-C, Lu N, Selig M, Nielsen G, Taksir T, Jain RK, Seed B (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94:715–725
Radisky E, Radisky D (2007) Stromal induction of breast cancer: inflammation and invasion. Rev Endocr Metab Disord 8(3):279–287
Condeelis J, Segall JE (2003) Intravital imaging of cell movement in tumours. Nat Rev Cancer 3:921–930
Porter D, Krop I, Nasser S, Sgroi D, Kaelin C, Marks J, Riggins G, Polyak K (2001) A SAGE (Serial Analysis of Gene Expression) view of breast tumor progression. Cancer Res 61:5697–5702